insights_auto
Hvorfor er REGN34 faldet med 4,14%?
Dyk dybere nedchevron_right
REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
61,14Â R$
arrow_downward
-4,14%(-2,64) 1D
5. okt., 15.22.15 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for REGN34...
Ã…bn
61,25Â R$
Høj
61,25Â R$
Lav
60,22Â R$
Markedsværdi
75,02Â mia.
Gns. vol.
828,00
Volumen
3,43Â t
Højeste i 52 uger
73,13Â R$
Laveste i 52 uger
49,47Â R$
Aktier i omløb
101,14Â mio.
Antal ansatte
15Â t
Ã…bn
61,25Â R$
Høj
61,25Â R$
Lav
60,22Â R$
Markedsværdi
75,02Â mia.
Gns. vol.
828,00
Volumen
3,43Â t
Højeste i 52 uger
73,13Â R$
Laveste i 52 uger
49,47Â R$
Aktier i omløb
101,14Â mio.
Antal ansatte
15Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
AD HOC NEWS
·
for 5 timer siden
Seeking Alpha downgrades Regeneron stock to Hold
AD HOC NEWS
·
for 7 timer siden
Regeneron stock heads toward October 30 earnings after Q2 growth
AD HOC NEWS
·
for 1 dag siden
Regeneron expands Sanofi alliance. Regeneron stock trades at EUR 653.35.
The Globe and Mail
·
for 2 dage siden
Regeneron (REGN) Gets a Hold from Scotiabank
Profil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Om Regeneron Pharmaceuticals Inc BDR
Administrerende direktørLeonard Schleifer
Ansatte15,3Â t
Grundlagt1988
HovedsædeTarrytown, New York, USA
Sektor-
Websiteregeneron.com